PharmacyCodes



Alfeprol [Russian] en es it fr

Alfeprol [Russian] Brand names, Alfeprol [Russian] Analogs

Alfeprol [Russian] Brand Names Mixture

  • No information avaliable

Alfeprol [Russian] Chemical_Formula

C15H23NO2

Alfeprol [Russian] RX_link

No information avaliable

Alfeprol [Russian] fda sheet

Alfeprol [Russian] msds (material safety sheet)

Alfeprol [Russian] Synthesis Reference

Brandstrom et al., Acta Pharm. Suecica 3, 303 (1966)

Alfeprol [Russian] Molecular Weight

249.349 g/mol

Alfeprol [Russian] Melting Point

107-109 oC

Alfeprol [Russian] H2O Solubility

547 mg/L

Alfeprol [Russian] State

Solid

Alfeprol [Russian] LogP

3.144

Alfeprol [Russian] Dosage Forms

Tablet

Alfeprol [Russian] Indication

For the treatment of hypertension, angina, and arrhythmia

Alfeprol [Russian] Pharmacology

Alprenolol is a non-selective beta-blocker used in the treatment of hypertension, edema, ventricular tachycardias, and atrial fibrillation. Alprenolol impairs AV node conduction and decreases sinus rate and may also increase plasma triglycerides and decrease HDL-cholesterol levels. Alprenolol is nonpolar and hydrophobic, with low to moderate lipid solubility. Alprenolol has little to no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, alprenolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action.

Alfeprol [Russian] Absorption

No information avaliable

Alfeprol [Russian] side effects and Toxicity

LD50=597.0 mg/kg (Orally in rats)

Alfeprol [Russian] Patient Information

No information avaliable

Alfeprol [Russian] Organisms Affected

Humans and other mammals